ASHLEY MACKINTOSH: Open Payments
NPI 1366739385 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,606 in 109 payments from 41 companies in 2025. Trend: 2023 $1,765 · 2024 $2,361 · 2025 $2,606
Food & beverage: $2,553Education: $53
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 9 | $216 |
| PFIZER INC. | 9 | $203 |
| Novartis Pharmaceuticals Corporation | 9 | $202 |
| Janssen Biotech, Inc. | 7 | $157 |
| Genentech USA, Inc. | 4 | $99 |
| Lilly USA, LLC | 4 | $95 |
| Regeneron Healthcare Solutions, Inc. | 4 | $85 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $83 |
| TAIHO ONCOLOGY, INC. | 3 | $81 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $78 |
Products named: KEYTRUDA, IBRANCE, VERZENIO, SCEMBLIX, LIBTAYO, LONSURF, Nubeqa, BESREMI.
Industry payments across SC — which companies pay providers there.
